Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    TENX Current Ratio

    As of 2025-07-12, the Current Ratio of Tenax Therapeutics Inc (TENX) is 20.6.

    Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

    TENX Current Ratio - Historical Value
    DateValue
    2024-12-31 20.6
    2023-12-31 3.26
    2022-12-31 1.74
    2021-12-31 3.64
    2020-12-31 3.21
    2019-12-31 2.44
    2018-12-31 8.51
    2017-12-31 7.99
    2016-12-31 2.2
    2015-12-31 4.47
    TENX Current Ratio - Peers Comparison
    TickerNameValue
    950160.KQKolon TissueGene Inc0.1
    950200.KQPsomagen Inc2.57
    950220.KQNeoimmunetech Inc1.89
    ABBVAbbvie Inc0.66
    ADTXAditxt Inc0.09
    AMGNAmgen Inc1.26
    BCT.VBriacell Therapeutics Corp0.07
    BIXTBioxytran Inc0.01
    BNTCBenitec Biopharma Inc10.57
    BRTXBioRestorative Therapies Inc2.97
    BTI.VBioasis Technologies Inc0.7
    CRYOAmerican Cryostem Corp0.12
    GILDGilead Sciences Inc1.6
    GNBTGenerex Biotechnology Corp0.03
    GOVXGeoVax Labs Inc2.55
    HEM.VHemostemix Inc0.36
    ICO.ViCo Therapeutics Inc0.42
    INTIInhibitor Therapeutics Inc8.02
    LIFEaTyr Pharma Inc6.27
    MHTXManhattan Scientifics Inc0.03
    MRNAModerna Inc3.67
    PFNDPathfinder Cell Therapy Inc0.01
    PKTXProtoKinetix Inc-0.03
    PMN.TOProMIS Neurosciences Inc1.08
    PSTVPlus Therapeutics Inc0.34
    QBIOQ BioMed Inc0.01
    QPT.VQuest Pharmatech Inc0.19
    REGNRegeneron Pharmaceuticals Inc4.73
    SKYESkye Bioscience Inc16.32
    TELO.VTelo Genomics Corp14.66
    VRTXVertex Pharmaceuticals Inc2.69
    VXL.VVaxil Bio Ltd43.12
    XBIOXenetic Biosciences Inc7.37
    Tickers added to watchlist